Related Experiment Video
Updated: Jun 21, 2026

Construction of a Wireless-Enabled Endoscopically Implantable Sensor for pH Monitoring with Zero-Bias Schottky Diode-based Receiver
Published on: August 27, 2021
Statin use and risk of gastroduodenal ulcer and reflux esophagitis
Takaaki Fujii1, Toshihiro Nakabayashi, Shinji Hashimoto
1Department of General Surgical Science, Graduate School of Medicine, Gunma University, Gunma, Japan. ftakaaki@med.gunma-u.ac.jp
Background/Aims:
Several trials have demonstrated beneficial effects of statins in some biological activities that go beyond lipid lowering, suggesting that statins might have other therapeutic benefits. However, it remains to be determined whether statin use is correlated with upper gastrointestinal diseases. We investigated the effects of statin therapy on gastroduodenal ulcers or reflux esophagitis (RE) in a case-control study.
Methodology:
We identified 120 newly diagnosed gastroduodenal ulcer cases and 146 RE cases from endoscopic examinees in the Gunma Prefectural Cardiovascular Center. Two controls per case were respectively selected according to sex and age and we determined 240 and 292 controls. We calculated odds ratios (OR) and 95% confidence intervals (CI) of peptic ulcer and RE for statin use.
Results:
Statin use was not associated with the risk of peptic ulcer (OR 1.2; 95% CI 0.7-2.1), and no elevated OR of RE was shown (OR 0.8; 95%CI 0.5-1.4). Ever use of hydrophilic statins, or lipophilic statins was not associated with the risk of peptic ulcer or RE.
Conclusions:
Our results suggest that statin use might not be associated with peptic ulcer or RE. These findings indicate that statin therapy might be safe for patients with upper gastrointestinal disease.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Gastroesophageal Reflux Disease
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...